Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy

Luciano S. Pereira, Marcos P. Ávila, Luciana X. Salustiano, Alcio C. Paula, Emmanuel Arnhold, Timothy J McCulley

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: The management of nonarteritic anterior ischemic optic neuropathy centers around prevention of second eye involvement, without a uniformly accepted therapy for the involved eye. Several researchers have assessed the benefit of steroids with conflicting results. This experimental study was designed to evaluate the efficacy of a single intravitreal triamcinolone acetonide injection (IVTA) in preserving retinal ganglion cells (RGCs) in a rodent model of anterior ischemic optic neuropathy (rAION). METHODS: The rAION was induced in female Wistar rats. Animals were randomized into 3 groups: 1) untreated, 2) treated with 56 μg IVTA, and 3) intravitreal saline (placebo). Procedures were performed in the left eye, with the right eye serving as control. After 30 days, animals were sacrificed and eyes were assessed histologically for RGC number. RESULTS: The average number of RGC was significantly lower in rAION subgroups when compared with the control group (P < 0.001). No significant difference was seen between rAION eyes treated with IVTA, placebo, and untreated eyes (P > 0.05%). CONCLUSIONS: In this rodent model for AION, no therapeutic benefit of intravitreal steroid injection was identified.

Original languageEnglish (US)
Pages (from-to)561-565
Number of pages5
JournalJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Volume38
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Ischemic Optic Neuropathy
Triamcinolone Acetonide
Rodentia
Retinal Ganglion Cells
Injections
Intravitreal Injections
Steroids
Wistar Rats
Cell Count
Placebos
Research Personnel
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology

Cite this

Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy. / Pereira, Luciano S.; Ávila, Marcos P.; Salustiano, Luciana X.; Paula, Alcio C.; Arnhold, Emmanuel; McCulley, Timothy J.

In: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, Vol. 38, No. 4, 01.12.2018, p. 561-565.

Research output: Contribution to journalArticle

@article{b01ab445a999458aa505c060488c465c,
title = "Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy",
abstract = "INTRODUCTION: The management of nonarteritic anterior ischemic optic neuropathy centers around prevention of second eye involvement, without a uniformly accepted therapy for the involved eye. Several researchers have assessed the benefit of steroids with conflicting results. This experimental study was designed to evaluate the efficacy of a single intravitreal triamcinolone acetonide injection (IVTA) in preserving retinal ganglion cells (RGCs) in a rodent model of anterior ischemic optic neuropathy (rAION). METHODS: The rAION was induced in female Wistar rats. Animals were randomized into 3 groups: 1) untreated, 2) treated with 56 μg IVTA, and 3) intravitreal saline (placebo). Procedures were performed in the left eye, with the right eye serving as control. After 30 days, animals were sacrificed and eyes were assessed histologically for RGC number. RESULTS: The average number of RGC was significantly lower in rAION subgroups when compared with the control group (P < 0.001). No significant difference was seen between rAION eyes treated with IVTA, placebo, and untreated eyes (P > 0.05{\%}). CONCLUSIONS: In this rodent model for AION, no therapeutic benefit of intravitreal steroid injection was identified.",
author = "Pereira, {Luciano S.} and {\'A}vila, {Marcos P.} and Salustiano, {Luciana X.} and Paula, {Alcio C.} and Emmanuel Arnhold and McCulley, {Timothy J}",
year = "2018",
month = "12",
day = "1",
doi = "10.1097/WNO.0000000000000639",
language = "English (US)",
volume = "38",
pages = "561--565",
journal = "Journal of Neuro-Ophthalmology",
issn = "1070-8022",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy

AU - Pereira, Luciano S.

AU - Ávila, Marcos P.

AU - Salustiano, Luciana X.

AU - Paula, Alcio C.

AU - Arnhold, Emmanuel

AU - McCulley, Timothy J

PY - 2018/12/1

Y1 - 2018/12/1

N2 - INTRODUCTION: The management of nonarteritic anterior ischemic optic neuropathy centers around prevention of second eye involvement, without a uniformly accepted therapy for the involved eye. Several researchers have assessed the benefit of steroids with conflicting results. This experimental study was designed to evaluate the efficacy of a single intravitreal triamcinolone acetonide injection (IVTA) in preserving retinal ganglion cells (RGCs) in a rodent model of anterior ischemic optic neuropathy (rAION). METHODS: The rAION was induced in female Wistar rats. Animals were randomized into 3 groups: 1) untreated, 2) treated with 56 μg IVTA, and 3) intravitreal saline (placebo). Procedures were performed in the left eye, with the right eye serving as control. After 30 days, animals were sacrificed and eyes were assessed histologically for RGC number. RESULTS: The average number of RGC was significantly lower in rAION subgroups when compared with the control group (P < 0.001). No significant difference was seen between rAION eyes treated with IVTA, placebo, and untreated eyes (P > 0.05%). CONCLUSIONS: In this rodent model for AION, no therapeutic benefit of intravitreal steroid injection was identified.

AB - INTRODUCTION: The management of nonarteritic anterior ischemic optic neuropathy centers around prevention of second eye involvement, without a uniformly accepted therapy for the involved eye. Several researchers have assessed the benefit of steroids with conflicting results. This experimental study was designed to evaluate the efficacy of a single intravitreal triamcinolone acetonide injection (IVTA) in preserving retinal ganglion cells (RGCs) in a rodent model of anterior ischemic optic neuropathy (rAION). METHODS: The rAION was induced in female Wistar rats. Animals were randomized into 3 groups: 1) untreated, 2) treated with 56 μg IVTA, and 3) intravitreal saline (placebo). Procedures were performed in the left eye, with the right eye serving as control. After 30 days, animals were sacrificed and eyes were assessed histologically for RGC number. RESULTS: The average number of RGC was significantly lower in rAION subgroups when compared with the control group (P < 0.001). No significant difference was seen between rAION eyes treated with IVTA, placebo, and untreated eyes (P > 0.05%). CONCLUSIONS: In this rodent model for AION, no therapeutic benefit of intravitreal steroid injection was identified.

UR - http://www.scopus.com/inward/record.url?scp=85055116052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055116052&partnerID=8YFLogxK

U2 - 10.1097/WNO.0000000000000639

DO - 10.1097/WNO.0000000000000639

M3 - Article

C2 - 29521709

AN - SCOPUS:85055116052

VL - 38

SP - 561

EP - 565

JO - Journal of Neuro-Ophthalmology

JF - Journal of Neuro-Ophthalmology

SN - 1070-8022

IS - 4

ER -